Curatis, Public Offering Price 4,000 Won... Below Desired Range Level
Curatis announced on the 2nd that it has finalized the public offering price at 4,000 KRW after conducting a demand forecast targeting institutional investors. This is below the expected range of 6,500 to 8,000 KRW.
A total of 435 institutions participated in the demand forecast held on the 30th and 31st of last month, recording a final competition rate of 52.89 to 1.
Curatis plans to proceed with subscription for general investors on the 5th and 7th, and is scheduled to be listed on the KOSDAQ market on the 15th. The lead underwriters are Daishin Securities and ShinYoung Securities.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- [Breaking] Central Labor Relations Commission: "Second Post-Mediation Fails for Samsung Electronics"
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "Looks Even More Like Him in Person": Crowds Gather to See 'Trump Lookalike' Albino Buffalo
- "Even With a 90 Million Won Salary and Bonuses, It Doesn’t Feel Like Much"... A Latecomer Rookie Who Beat 70 to 1 Odds [Scientists Are Disappearing] ③
Curatis is a vaccine and immune disease treatment company established in 2016, developing the adult and adolescent tuberculosis vaccine 'QTP101'.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
